- Home
- ESCA vs PRME Comparison
ESCA vs PRME Comparison
Compare ESCA & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESCA
- PRME
- Stock Information
- Founded
- ESCA 1922
- PRME 2019
- Country
- ESCA United States
- PRME United States
- Employees
- ESCA N/A
- PRME N/A
- Industry
- ESCA Recreational Games/Products/Toys
- PRME Medicinal Chemicals and Botanical Products
- Sector
- ESCA Consumer Discretionary
- PRME Health Care
- Exchange
- ESCA Nasdaq
- PRME Nasdaq
- Market Cap
- ESCA 198.5M
- PRME 191.7M
- IPO Year
- ESCA N/A
- PRME 2022
- Fundamental
- Price
- ESCA $12.15
- PRME $3.57
- Analyst Decision
- ESCA
- PRME Buy
- Analyst Count
- ESCA 0
- PRME 6
- Target Price
- ESCA N/A
- PRME $8.88
- AVG Volume (30 Days)
- ESCA 17.7K
- PRME 4.4M
- Earning Date
- ESCA 08-01-2025
- PRME 08-07-2025
- Dividend Yield
- ESCA 4.94%
- PRME N/A
- EPS Growth
- ESCA 10.02
- PRME N/A
- EPS
- ESCA 0.92
- PRME N/A
- Revenue
- ESCA $241,492,000.00
- PRME $4,961,000.00
- Revenue This Year
- ESCA N/A
- PRME $126.92
- Revenue Next Year
- ESCA N/A
- PRME $87.32
- P/E Ratio
- ESCA $13.19
- PRME N/A
- Revenue Growth
- ESCA N/A
- PRME 739.42
- 52 Week Low
- ESCA $11.74
- PRME $1.11
- 52 Week High
- ESCA $16.99
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- ESCA 42.97
- PRME 46.93
- Support Level
- ESCA $11.74
- PRME $3.35
- Resistance Level
- ESCA $13.23
- PRME $3.88
- Average True Range (ATR)
- ESCA 0.48
- PRME 0.38
- MACD
- ESCA 0.08
- PRME -0.12
- Stochastic Oscillator
- ESCA 27.52
- PRME 16.00
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.